These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
236 related items for PubMed ID: 18550587
1. Acquired factor VIII and von Willebrand factor (aFVIII/VWF) deficiency and hypothyroidism in a case with hypopituitarism. Oliveira MC, Kramer CK, Marroni CP, Leães CG, Viana L, Roithman S, Schmaedecke A, Pereira-Lima JF. Clin Appl Thromb Hemost; 2010 Feb; 16(1):107-9. PubMed ID: 18550587 [Abstract] [Full Text] [Related]
2. Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidism. Levesque H, Borg JY, Cailleux N, Vasse M, Daliphard S, Gancel A, Monconduit M, Courtois H. Eur J Med; 1993 May; 2(5):287-8. PubMed ID: 8252160 [Abstract] [Full Text] [Related]
3. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions. Jacquemin M. Acta Haematol; 2009 May; 121(2-3):102-5. PubMed ID: 19506355 [Abstract] [Full Text] [Related]
4. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1. Michiels JJ, Gadisseur A, Vangenegten I, Schroyens W, Berneman Z. Acta Haematol; 2009 May; 121(2-3):119-27. PubMed ID: 19506358 [Abstract] [Full Text] [Related]
5. Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort study. Stuijver DJ, Piantanida E, van Zaane B, Galli L, Romualdi E, Tanda ML, Meijers JC, Büller HR, Gerdes VE, Squizzato A. Haemophilia; 2014 May; 20(3):326-32. PubMed ID: 24118466 [Abstract] [Full Text] [Related]
12. DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor. Casonato A, Dannhauser D, Pontara E, Bertomoro A, Orazi B, Santarossa L, Zerbinati P, Girolami A. Blood Coagul Fibrinolysis; 1996 Jul 13; 7(5):549-53. PubMed ID: 8874865 [Abstract] [Full Text] [Related]
16. Causes, etiology and diagnosis of acquired von Willebrand disease: a prospective diagnostic workup to establish the most effective therapeutic strategies. Sucker C, Michiels JJ, Zotz RB. Acta Haematol; 2009 Jan 13; 121(2-3):177-82. PubMed ID: 19506364 [Abstract] [Full Text] [Related]
17. The factor VIII/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor. Eikenboom JC, Castaman G, Kamphuisen PW, Rosendaal FR, Bertina RM. Thromb Haemost; 2002 Feb 13; 87(2):252-7. PubMed ID: 11859851 [Abstract] [Full Text] [Related]
18. Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications. Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, Budde U, van Vliet HH. Semin Thromb Hemost; 2006 Sep 13; 32(6):577-88. PubMed ID: 16977568 [Abstract] [Full Text] [Related]